{"id":13704,"date":"2021-01-26T23:03:05","date_gmt":"2021-01-26T23:03:05","guid":{"rendered":"https:\/\/clinlabint.com\/?p=13704"},"modified":"2021-01-29T00:39:19","modified_gmt":"2021-01-29T00:39:19","slug":"randox-labs-releases-whole-pathogen-multiplex-controls-to-support-testing-for-cold-cough-and-covid","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/randox-labs-releases-whole-pathogen-multiplex-controls-to-support-testing-for-cold-cough-and-covid\/","title":{"rendered":"Randox Labs releases whole pathogen multiplex controls to support testing for cold, cough and COVID"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

Randox Labs releases whole pathogen multiplex controls to support testing for cold, cough and COVID<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

Global diagnostics company Randox Laboratories has unveiled a range of whole pathogen multiplex controls that cover multiple viral and bacterial pathogens which cause respiratory disease.<\/p>\n

<\/p>\n

Inclusive of SARS-CoV-2, Influenza A & B, and Adenovirus, the Qnostics Multiplex Respiratory Pathogen Controls (RTX) facilitate diagnosis of the likes of cold and flu, and importantly, the differentiation of these respiratory diseases from COVID-19.<\/p>\n

Using a control line that covers a range of respiratory pathogens allows laboratories to streamline their testing, consolidate QC, and ultimately save time, money and resources.<\/p>\n

The new RTX controls, which are whole pathogen for compatibility with most commercial and in-house assays, are used to monitor the full testing process, from extraction to amplification and detection.<\/p>\n

The Multiplex Respiratory Controls will support public health testing strategies during the incoming flu season and are suited for the test menus of most syndromic assays.<\/p>\n

Lynsey Adams, Randox Quality Control Manager, explained: \u201cThe Randox Qnostics Multiplex Respiratory Pathogen Controls are clinically relevant for full-process validation. Liquid frozen for user convenience and ease of use, the development of the controls using whole pathogen material ensures clinical relevance from extraction to amplification and detection.\u201d<\/p>\n

Randox Qnostics Multiplex Respiratory Pathogen Controls are manufactured to ISO 13485 standards and are in line with ISO 15189:2012 regulatory requirements.<\/p>\n

Key features and benefits of the new RTX Controls:<\/strong><\/p>\n